Stock Scorecard
Stock Summary for Personalis Inc (PSNL) - $5.37 as of 9/7/2024 11:10:42 AM EST
Total Score
11 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PSNL
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PSNL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PSNL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PSNL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for PSNL
Financial Details for PSNL
Company Overview |
|
|---|---|
| Ticker | PSNL |
| Company Name | Personalis Inc |
| Country | USA |
| Description | Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-MEDICAL LABORATORIES |
| Most Recent Quarter | 6/30/2024 |
| Next Earnings Date | 11/5/2024 |
Stock Price History |
|
| Last Day Price | 5.37 |
| Last Day Price Updated | 9/7/2024 11:10:42 AM EST |
| Last Day Volume | 695,504 |
| Average Daily Volume | 1,480,573 |
| 52-Week High | 7.20 |
| 52-Week Low | 0.89 |
| Last Price to 52 Week Low | 503.37% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 108.71 |
| Sector PE | 80.12 |
| 5-Year Average PE | -8.91 |
| Free Cash Flow Ratio | 4.07 |
| Industry Free Cash Flow Ratio | 35.78 |
| Sector Free Cash Flow Ratio | 30.42 |
| Current Ratio Most Recent Quarter | 3.31 |
| Total Cash Per Share | 1.32 |
| Book Value Per Share Most Recent Quarter | 2.12 |
| Price to Book Ratio | 3.14 |
| Industry Price to Book Ratio | 2.76 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 4.42 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.74 |
| Sector Price to Sales Ratio Twelve Trailing Months | 6.66 |
Share Statistics |
|
| Total Shares Outstanding | 65,935,000 |
| Market Capitalization | 354,070,950 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 4.43% |
| Reported EPS 12 Trailing Months | -1.64 |
| Reported EPS Past Year | -0.50 |
| Reported EPS Prior Year | -2.13 |
| Net Income Twelve Trailing Months | -81,452,000 |
| Net Income Past Year | -108,296,000 |
| Net Income Prior Year | -113,315,000 |
| Quarterly Revenue Growth YOY | 35.20% |
| 5-Year Revenue Growth | 2.99% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 86,972,000 |
| Total Cash Past Year | 114,179,000 |
| Total Cash Prior Year | 167,658,000 |
| Net Cash Position Most Recent Quarter | 85,411,000 |
| Net Cash Position Past Year | 112,533,000 |
| Long Term Debt Past Year | 1,646,000 |
| Long Term Debt Prior Year | 2,218,000 |
| Total Debt Most Recent Quarter | 1,561,000 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 0.99 |
| Total Stockholder Equity Past Year | 129,441,000 |
| Total Stockholder Equity Prior Year | 218,139,000 |
| Total Stockholder Equity Most Recent Quarter | 112,272,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -65,757,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.00 |
| Free Cash Flow Past Year | -67,169,000 |
| Free Cash Flow Prior Year | -120,129,000 |
Options |
|
| Put/Call Ratio | 0.80 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.54 |
| MACD Signal | 0.71 |
| 20-Day Bollinger Lower Band | -0.78 |
| 20-Day Bollinger Middle Band | 2.68 |
| 20-Day Bollinger Upper Band | 6.14 |
| Beta | 1.92 |
| RSI | 54.31 |
| 50-Day SMA | 4.19 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 9.91 |
System |
|
| Modified | 9/7/2024 11:10:43 AM EST |